Randomised controlled trials, including the National Lung Screening Trial (NLST) and the
NELSON trial, have shown reduced mortality with lung cancer screening with low-dose CT …

Background Screening for lung cancer with low radiation dose computed tomography has a
strong evidence base, is being introduced in several European countries and is …

Patients with chronic obstructive pulmonary disease (COPD) are at increased risk of
cardiovascular disease (CVD) and concomitant disease leads to reduced quality of life …

Low-dose computed tomography (LDCT) screening for lung cancer substantially reduces
mortality from lung cancer, as revealed in randomized controlled trials and meta-analyses …

Lung cancer is the leading cause of cancer death worldwide. The absence of symptoms in
early-stage (I/II) disease, when curative treatment is possible, results in> 70% of cases being …

Background Lung cancer risk prediction models do not routinely incorporate imaging metrics
available on low-dose CT (LDCT) imaging of the chest ordered for lung cancer screening …

Lung cancer is the number one cause of cancer death worldwide. The benefits of lung
cancer screening to reduce mortality and detect early‐stage disease are no longer in any …

Smoking is the main risk factor for lung cancer (LC), which is the leading cause of cancer-
related death worldwide. Independent randomized controlled trials, governmental and inter …

The ITALUNG trial started in 2004 and compared lung cancer (LC) and other-causes
mortality in 55–69 years-aged smokers and ex-smokers who were randomized to four …

Lung cancer survival statistics are sobering with survival ranking among the poorest of all
cancers despite the addition of targeted therapies and immunotherapies. However …